BR9908566A - Composição farmacêutica para profilaxia e terapia de doenças associadas a citopatia do tecido do fundo ocular - Google Patents

Composição farmacêutica para profilaxia e terapia de doenças associadas a citopatia do tecido do fundo ocular

Info

Publication number
BR9908566A
BR9908566A BR9908566-6A BR9908566A BR9908566A BR 9908566 A BR9908566 A BR 9908566A BR 9908566 A BR9908566 A BR 9908566A BR 9908566 A BR9908566 A BR 9908566A
Authority
BR
Brazil
Prior art keywords
prophylaxis
therapy
pharmaceutical composition
carbon atoms
diseases associated
Prior art date
Application number
BR9908566-6A
Other languages
English (en)
Inventor
Mitsuyoshi Azuma
Yukuo Yoshida
Yuji Sakamoto
Jun Inoue
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of BR9908566A publication Critical patent/BR9908566A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Patente de Invenção: <B>"COMPOSIçãO FARMACêUTICA PARA PROFILAXIA E TERAPIA DE DOENçAS ASSOCIADAS A CITOPATIA DO TECIDO DO FUNDO OCULAR"<D>. Esta invenção refere-se a uma composição farmacêutica para a profilaxia de terapia de uma doença que se origina de citopatia do tecido do fundo ocular tais como doença retinocoroidal, glaucoma e complicação posterior que se origina de fotocoagulacão, composição esta que contém, como ingrediente ativo, um composto de fórmula (I) onde R¹ representa um grupo alquila com 1 a 4 átomos de carbono ou um grupo arila com 6 a 10 átomos de carbono que é opcionalmente substituído; R² e R³ poderão ser os mesmos ou diferentes e cada um representa hidrogênio ou um grupo alquila com 1 a 4 átomos de carbono, ou R² e R³ poderão juntamente formar um anel com 3 a 7 átomos de carbono; e R^ 4^ representa um grupo alquila inferior que é opcionalmente substituído por arila, cicloalquila ou resíduo heterocíclico aromático, ou um sal farmaceuticamente aceitável do composto.
BR9908566-6A 1998-03-05 1999-03-03 Composição farmacêutica para profilaxia e terapia de doenças associadas a citopatia do tecido do fundo ocular BR9908566A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5362498 1998-03-05
PCT/JP1999/001031 WO1999044624A2 (en) 1998-03-05 1999-03-03 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy

Publications (1)

Publication Number Publication Date
BR9908566A true BR9908566A (pt) 2000-11-21

Family

ID=12948075

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908566-6A BR9908566A (pt) 1998-03-05 1999-03-03 Composição farmacêutica para profilaxia e terapia de doenças associadas a citopatia do tecido do fundo ocular

Country Status (17)

Country Link
US (1) US6423691B1 (pt)
EP (2) EP1058553B1 (pt)
JP (1) JP4422894B2 (pt)
KR (1) KR20010041605A (pt)
CN (1) CN1298304A (pt)
AR (1) AR018576A1 (pt)
AT (2) ATE296635T1 (pt)
AU (1) AU2745599A (pt)
BR (1) BR9908566A (pt)
CA (1) CA2322854A1 (pt)
DE (2) DE69939075D1 (pt)
HU (1) HUP0101733A3 (pt)
ID (1) ID27083A (pt)
NO (1) NO20004405L (pt)
PL (1) PL343412A1 (pt)
WO (1) WO1999044624A2 (pt)
ZA (1) ZA991749B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001292287A1 (en) 2000-10-26 2002-05-06 Senju Pharmaceutical Co. Ltd. Drug composition comprising dipeptydyl aldehyde derivative
AU2003248059A1 (en) * 2002-07-22 2004-02-09 Senju Pharmaceutical Co., Ltd. NOVEL Alpha-KETOAMIDE DERIVATIVE AND USE THEREOF
US7394598B2 (en) 2002-09-19 2008-07-01 Koninklijke Philips Electronics N.V. Electrowetting optical switch
AU2003292838A1 (en) * 2002-12-27 2004-07-29 Kirin Beer Kabushiki Kaisha Therapeutic agent for wet age-related macular degeneration
KR20170070274A (ko) 2009-05-29 2017-06-21 펄 테라퓨틱스 인코포레이티드 지속형 무스카린 안타고니스트 및 지속형 ｂ₂아드레날린 수용체 아고니스트의 폐 전달용 조성물, 및 연관된 방법 및 시스템
JPWO2011105070A1 (ja) 2010-02-25 2013-06-20 パナソニック株式会社 需給制御装置、需給制御方法、およびプログラム
EP2593089B1 (en) 2010-07-14 2018-04-04 Senju Pharmaceutical Co., Ltd. Solid dispersion of alfa-ketoamide derivative
RU2452436C1 (ru) * 2011-01-31 2012-06-10 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения атрофии зрительного нерва сосудистого генеза
KR102354410B1 (ko) * 2014-02-21 2022-01-21 다이니뽄 스미토모 세이야쿠 가부시키가이샤 눈 질환 치료제, 이의 스크리닝 방법, 및 망막 색소 상피 세포 이식과 연관된 거부 반응의 예측 방법
AU2016320905B2 (en) 2015-09-11 2021-10-07 The Schepens Eye Research Institute, Inc. Compositions and methods for prevention and treatment of corneal haze and scarring
US11439608B2 (en) 2017-09-25 2022-09-13 Qun Lu Roles of modulators of intersectin-CDC42 signaling in Alzheimer's disease
PL424452A1 (pl) * 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0504938A3 (en) 1991-03-22 1993-04-14 Suntory Limited Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient
JP2848232B2 (ja) * 1993-02-19 1999-01-20 武田薬品工業株式会社 アルデヒド誘導体
JP3599287B2 (ja) 1993-04-28 2004-12-08 三菱化学株式会社 スルホンアミド誘導体
EP0731107A1 (en) 1995-02-13 1996-09-11 Takeda Chemical Industries, Ltd. Production of aldehyde derivatives
ATE230275T1 (de) 1995-10-25 2003-01-15 Senju Pharma Co Angiogense-inhibitor
KR100490807B1 (ko) * 1995-11-28 2005-10-14 세파론, 인코포레이티드 시스테인및세린프로테아제의d-아미노산함유억제제
DE19718826A1 (de) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung

Also Published As

Publication number Publication date
ID27083A (id) 2001-02-22
CN1298304A (zh) 2001-06-06
WO1999044624A2 (en) 1999-09-10
JP2002505297A (ja) 2002-02-19
US6423691B1 (en) 2002-07-23
EP1504760A1 (en) 2005-02-09
ATE400277T1 (de) 2008-07-15
CA2322854A1 (en) 1999-09-10
WO1999044624A3 (en) 1999-10-21
DE69925578D1 (de) 2005-07-07
ATE296635T1 (de) 2005-06-15
EP1058553A2 (en) 2000-12-13
HUP0101733A2 (hu) 2001-11-28
AU2745599A (en) 1999-09-20
DE69925578T2 (de) 2006-04-27
EP1504760B1 (en) 2008-07-09
HUP0101733A3 (en) 2001-12-28
AR018576A1 (es) 2001-11-28
DE69939075D1 (de) 2008-08-21
ZA991749B (en) 1999-09-16
EP1058553B1 (en) 2005-06-01
NO20004405L (no) 2000-11-03
PL343412A1 (en) 2001-08-13
JP4422894B2 (ja) 2010-02-24
KR20010041605A (ko) 2001-05-25
NO20004405D0 (no) 2000-09-04

Similar Documents

Publication Publication Date Title
MX2020000261A (es) Nuevos compuestos.
BRPI0616574A2 (pt) derivado de sulfonamida tendo atividade antagonìstica de receptor de pgd2
ES2182852T3 (es) Derivados de prolinamida.
BR9908566A (pt) Composição farmacêutica para profilaxia e terapia de doenças associadas a citopatia do tecido do fundo ocular
PT1029853E (pt) Derivados biciclicos heteroaromaticos uteis como agentes anticancerigenos
PH12021551256A1 (en) Pantetheine derivatives and uses thereof
BR9807132A (pt) Derivados de pirrolidina tendo atividade inibitória de fosfolipase a2
ATE319458T1 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
HUP0202745A2 (hu) Profilaktikus és terápiás szerek szembetegségek kezelésére
NO20032261L (no) Medisinske preparater
BR0114424A (pt) Derivados de 5-amidino-2-hidróxi benzeno sulfonamida, composições farmacêuticas contendo os mesmos e intermediários para a sua preparação
ES2109752T3 (es) Medicamento para tratamiento terapeutico y profilactico de enfermedades causadas por hiperplasia de las celulas de los musculos lisos.
BR0110871A (pt) Derivados de sulfonamida
BR0110874A (pt) Derivados de sulfonamida
BR9908948A (pt) Composição farmacêutica contendo um inibidor de protease cisteìna para profilaxia e terapia de dano ao tecido cerebral
IT1313583B1 (it) Derivati 2-amminotetralinici per la terapia del glaucoma.
BR0110363A (pt) Derivados pirimidinil metil indol com atividade antibacterial
ES2141134T3 (es) Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares.
BR0314930A (pt) Derivados de pirazol e seu uso como agentes terapêuticos para doenças mediadas por hiv
BR9815690A (pt) Composto, processo para a preparação de qualquer um dos compostos, composição farmacêutica, e, uso do composto de 3-(nafter-1-il-óxi) - pirrolidina, 3-(5,6,7,8 - tetraidro-nafterc-1-il-óxi) - pirrolindina
DE60026559D1 (de) Arzneimittel gegen essstörungen

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]